ECOPOSITIVE PET BOTTLES

Bormioli Rocco S.P.A offers a wide range of glass bottles for oral solids which includes te silica gel pfp 28. It belongs to tamper evident closures category. Contact us for more information.

Bormioli Rocco S.P.A offers a wide range of glass bottles for oral solids which includes te silica gel pfp 35. It belongs to tamper evident closures category. Contact us for more information.

Bormioli Rocco S.P.A offers a wide range of glass bottles for oral liquid which includes traditional adapter. It belongs to packaging pediatrico traditional category. Contact us for more information.

Bormioli Rocco S.P.A offers a wide range of glass bottles for oral liquid which includes traditional crc. It belongs to packaging pediatrico traditional category. Contact us for more information.

Bormioli Rocco S.P.A offers a wide range of glass bottles for oral liquid which includes vetro pfp 28. It belongs to glass bottles for syrups 2000 series category. Contact us for more information.

An oral drug reconstitution system that protects the active ingredients of formulations and extends their shelf life. The design is conceived to ensure the exact reconstitution of pre-dosed ingredients, making the process repeatability and simple. Our dual-chamber kits are available with different capaciti...

Bormioli Pharma offers a complete range of medical devices for administering and measuring drugs, including spoons, measuring cups and graduated syringes. All the solutions are fully compatible with our packaging range.

Our rubbers stopper closure proposal is fully combinable with the entire range of our injectable drug bottles, both tubular and molded, and are available for ISO 13, ISO 20, IS0 32 neck finishes. Strict in-line controls and specific sterilisation services ensure top quality and safety standards.

Our wide range of tear-off gears are highly customizable and available for all neck finishes, ensure proper protection for the drug contents and effective use for healthcare professionals. Neck finishes are available from 13 mm to 32 mm available.

Our Type I molded glass bottles are designed to meet the needs of high-value injectable therapies. Our proposal includes a wide range of formats, compatible with an equally extensive offer of rubber stoppers and alu-gears. The bottles and the vials are made using advanced manufacturing technology, which en...

Our Type I tubular glass bottles, suitable for parenteral and laboratory applications, are made in accordance with the main product guidelines internationally, and the glass tube is purchased from selected European suppliers. Thanks to our broad product offer, each solution can be completed with a compatib...

Thanks an extended material expertise, strong production capability and flexibility, we offer Type II and Type I molded glass bottles for every drug requirement and every administration.
Our clients can choose among solutions from 1.5 ml to 3000 ml of capacity and every neck finish available on the ma...

CPHI releases its Sustainability Trend Report focusing on carbon emissions in the supply chain and working towards a greener future in the pharmaceutical industry.

Bormioli Pharma has developed a solid and extensive patient-centric innovation program intended to advise the pharma industry along the entire drug development process, from early stage compatibility assessment up to the production of parts needed for drug fileing, clinical trials and commercialization. In the current healthcare domain where personalized medicine, biosimilars, gene-cell therapies, orphan drugs new formulation are becoming increasingly important, the choice and the development of the most appropriate pharmaceutical primary packaging is fundamental for success. Blending patient knowledge, an innovator DNA and leveraging at the same time on a robust industrial footprint is a distinctive capability and can be instrumental for building valuable co-partnership with the pharmaceutical industry. Bormioli Pharma will share details on its “Invents Department” and how biopharma companies leveraged on our services to accelerate the adoption of their biotechnology-based therapies.

Implementing sustainability in pharmaceutical packaging needs a two-way methodology: on the one hand, a scientific, data-driven approach to support today’s industrial solutions; on the other hand, a ground-breaking , never-stopping innovation research to anticipate future evolutions. With this Learning Lab, Bormioli Pharma discloses in preview the three drivers which are defining the Group’s mid-long strategy in terms of product sustainability, opening-up the debate to a qualified audience of pharmaceutical professionals. Why attending the Learning Lab? Having a clear picture of all the sustainable packaging solutions now available on the market; Grasping the occasion to be updated on the latest development directions; Clearly understanding opportunities to implement sustainable packaging in your business.

In this webinar, originally part of Pharmapack Europe 2022, Roberto Valenti, Head of Materials Development, Bormioli Pharma talks about combining sustainable packaging with pharma requirements. Strict regulatory frameworks and rigorous safety standards lead many to believe that pharma requirements and sustainability are not a simple match. Bormioli Pharma’s 15-year-long research into the field of sustainable pharma packaging demonstrates that data makes the difference. With this Learning Lab, participants gain useful insight into the latest eco-friendly packaging solutions for medicines, along with a scientific demonstration of the chemical safety of these containers and their positive impact on the environment.